GenMark Diagnostics Schedules First Quarter Financial Results Conference Call for May 1, 2018
April 17 2018 - 4:03PM
GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it
plans to release its first quarter earnings results after market
close on Tuesday, May 1, 2018. Management will hold a
conference call to review the Company's financial performance
starting at 4:30 p.m. ET on the same day. The conference
call will be concurrently webcast. The link to the webcast will be
available on the GenMark Diagnostics, Inc. website
at www.genmarkdx.com under the investor relations section and
will be archived for future reference. To listen to the conference
call, please dial (877) 312-5847 (US/Canada) or (253) 237-1154
(International) and use the conference ID number 9384229
approximately five minutes prior to the start time.
ABOUT GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of
multiplex molecular diagnostic solutions designed to enhance
patient care, improve key quality metrics, and reduce the total
cost-of-care. Utilizing GenMark's proprietary eSensor® detection
technology, GenMark's eSensor XT-8® and ePlex® systems are designed
to support a broad range of molecular diagnostic tests with
compact, easy-to-use workstations and self-contained, disposable
test cartridges. GenMark’s ePlex: The True Sample-to-Answer
Solution™ is designed to optimize laboratory efficiency and address
a broad range of infectious disease testing needs, including
respiratory, bloodstream, and gastrointestinal infections.
For more information, visit www.genmarkdx.com.
Investor Relations Contact Lynn
Pieper Lewis or Leigh Salvo
(415) 937-5404
ir@genmarkdx.com
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Apr 2024 to May 2024
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From May 2023 to May 2024